GvHD biomarkers measured during treatment independently predict response to therapy and survival: A Blood and Marrow Transplant Clinical Trials Network Study

被引：0
|
作者：
Levine, J. E. [1 ]
Logan, B. [2 ]
Wu, J. [3 ]
Alousi, A. M. [4 ]
Bolanos-Meade, J. [5 ]
Ho, V. [6 ]
Weisdorf, D. J. [7 ]
Paczesny, S. [1 ]
机构：
[1] Univ Michigan, Ann Arbor, MI 48109 USA
[2] Ctr Int Blood & Marrow Transplant Res, Milwaukee, WI USA
[3] EMMES Corp, Rockville, MD USA
[4] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[5] Johns Hopkins Univ, Baltimore, MD USA
[6] Dana Farber Canc Inst, Boston, MA 02115 USA
[7] Univ Minnesota, Minneapolis, MN USA
来源：
BONE MARROW TRANSPLANTATION | 2011年 / 46卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S8 / S9
页数：2
相关论文
共 50 条
  • [41] DEVELOPMENT AND MANAGEMENT OF A MULTI-CENTER, CENTER-SPECIFIC CELLULAR THERAPY MANUFACTURING APPROACH: THE EXPERIENCE OF THE BLOOD AND MARROW TRANSPLANT CLINICAL TRIALS NETWORK (BMT CTN) PROTOCOL #1401
    Nelson, C. L.
    O'Brien, K.
    Mendizabal, A.
    Gersten, I.
    Uhl, L.
    Chung, D.
    Shah, N.
    Avigan, D.
    Pasquini, M.
    CYTOTHERAPY, 2017, 19 (05) : S84 - S84
  • [42] Follistatin and Endoglin: Potential Biomarkers of Endothelial Damage and Non-Relapse Mortality after Myeloablative Allogeneic Hematopoietic Cell Transplantation in Blood and Marrow Transplant Clinical Trials Network (BMT CTN) 0402
    Newell, Laura F.
    DeFor, Todd E.
    Cutler, Corey S.
    Verneris, Michael R.
    Blazar, Bruce R.
    Antin, Joseph H.
    Howard, Alan
    Wu, Juan
    MacMillan, Margaret L.
    Panoskaltsis-Mortari, Angela
    Weisdorf, Daniel J.
    Holtan, Shernan G.
    BLOOD, 2016, 128 (22)
  • [43] Follistatin and Endoglin: Potential Biomarkers of Endothelial Damage and Non-Relapse Mortality after Myeloablative Allogeneic Hematopoietic Cell Transplantation in Blood and Marrow Transplant Clinical Trials Network (BMT CTN) 0402
    Newell, Laura F.
    Defor, Todd E.
    Cutler, Corey S.
    Verneris, Michael R.
    Blazar, Bruce R.
    Antin, Joseph H.
    Howard, Alan
    Wu, Juan
    MacMillan, Margaret L.
    Panoskaltsis-Mortari, Angela
    Weisdorf, Daniel J.
    Holtan, Shernan
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (03) : S73 - S74
  • [44] Blood and Marrow Transplant Clinical Trials Network Study 1102 heralds a new era in hematopoietic cell transplantation in high-risk myelodysplastic syndromes: Challenges and opportunities in implementation
    Warlick, Erica D.
    Ustun, Celalettin
    Andreescu, Astrid
    Bonagura, Anthony F.
    Brunner, Andrew
    Chandra, Abhinav B.
    Foran, James M.
    Juckett, Mark B.
    Kindwall-Keller, Tamila L.
    Klimek, Virginia M.
    Pease, Daniel F.
    Steensma, David P.
    Waldman, Bryce M.
    Horowitz, Mary M.
    Burns, Linda J.
    Khera, Nandita
    CANCER, 2021, 127 (23) : 4339 - 4347
  • [45] Randomized, Double Blind, Placebo-Controlled Trial of a TNF Inhibitor (ETANERCEPT) for the Treatment of Idiopathic Pneumonia Syndrome (IPS) After Allogeneic Stem Cell Transplant (SCT). A Blood and Marrow Transplant Clinical Trials Network (BMT CTN) Study
    Yanik, Gregory
    Ho, Vincent T.
    Horowitz, Mary
    Weisdorf, Daniel J.
    Logan, Brent R.
    Wu, Juan
    Soiffer, Robert J.
    Wingard, John R.
    Levine, John E.
    Ferrara, James L. M.
    Giralt, Sergio A.
    White, Eric
    Carter, Shelly L.
    DiFronzo, Nancy
    Cooke, Kenneth R.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2013, 19 (02) : S169 - S169
  • [46] American Society of Blood and Marrow Transplantation, European Society of Blood and Marrow Transplantation, Blood and Marrow Transplant Clinical Trials Network, and International Myeloma Working Group Consensus Conference on Salvage Hematopoietic Cell Transplantation in Patients with Relapsed Multiple Myeloma
    Giralt, Sergio
    Garderet, Laurent
    Durie, Brian
    Cook, Gordon
    Gahrton, Gosta
    Bruno, Benedetto
    Hari, Paremesweran
    Lokhorst, Henk
    McCarthy, Phillip
    Krishnan, Amrita
    Sonneveld, Pieter
    Goldschmidt, Harmut
    Jagannath, Sundar
    Barlogie, Bart
    Mateos, Maria
    Gimsing, Peter
    Sezer, Orhan
    Mikhael, Joseph
    Lu, Jin
    Dimopoulos, Meletios
    Mazumder, Amitabha
    Palumbo, Antonio
    Abonour, Rafat
    Anderson, Kenneth
    Attal, Michel
    Blade, Joan
    Bird, Jenny
    Cavo, Michele
    Comenzo, Raymond
    de la Rubia, Javier
    Einsele, Hermann
    Garcia-Sanz, Ramon
    Hillengass, Jens
    Holstein, Sarah
    Johnsen, Hans Erik
    Joshua, Douglas
    Koehne, Guenther
    Kumar, Shaji
    Kyle, Robert
    Leleu, Xavier
    Lonial, Sagar
    Ludwig, Heinz
    Nahi, Hareth
    Nooka, Anil
    Orlowski, Robert
    Rajkumar, Vincent
    Reiman, Anthony
    Richardson, Paul
    Riva, Eloisa
    Miguel, Jesus San
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2015, 21 (12) : 2039 - 2051
  • [47] Increased Incidence of Chronic Graft-Versus-Host Disease (GVHD) and No Survival Advantage with Filgrastim-Mobilized Peripheral Blood Stem Cells (PBSC) Compared to Bone Marrow (BM) Transplants From Unrelated Donors: Results of Blood and Marrow Transplant Clinical Trials Network (BMT CTN) Protocol 0201, a Phase III, Prospective, Randomized Trial
    Anasetti, Claudio
    Logan, Brent R.
    Lee, Stephanie J.
    Waller, Edmund K.
    Weisdorf, Daniel J.
    Wingard, John R.
    Cutler, Corey S.
    Westervelt, Peter
    Woolfrey, Ann
    Couban, Stephen
    Johnston, Laura
    Maziarz, Richard T.
    Pulsipher, Michael
    Anderlini, Paolo
    Bensinger, William I.
    Leitman, Susan F.
    Rowley, Scott D.
    Carter, Shelly L.
    Horowitz, Mary M.
    Confer, Dennis L.
    BLOOD, 2011, 118 (21) : 3 - 3
  • [48] Recovery of Unrelated Donors of Peripheral Blood Stem Cells versus Recovery of Unrelated Donors of Bone Marrow: A Prespecified Analysis from the Phase III Blood and Marrow Transplant Clinical Trials Network Protocol 0201
    Burns, Linda J.
    Logan, Brent R.
    Chitphakdithai, Pintip
    Miller, John P.
    Drexler, Rebecca
    Spellman, Stephen
    Switzer, Galen E.
    Wingard, John R.
    Anasetti, Claudio
    Confer, Dennis L.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (06) : 1108 - 1116
  • [49] Functional and Radiologic Assessment of the Brain after Reduced-Intensity Unrelated Donor Transplantation for Severe Sickle Cell Disease: Blood and Marrow Transplant Clinical Trials Network Study 0601
    King, Allison A.
    McKinstry, Robert C.
    Wu, Juan
    Eapen, Mary
    Abel, Regina
    Varughese, Taniya
    Kamani, Naynesh
    Shenoy, Shalini
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (05) : E174 - E178
  • [50] The role of immunological and clinical biomarkers to predict clinical COVID-19 severity and response to therapy - A prospective longitudinal case-control study
    Copaescu, A.
    James, F.
    Mouhtouris, E.
    Vogrin, S.
    Smibert, O.
    Gordon, C.
    Drewett, G.
    Holmes, N. E.
    Trubiano, J. A.
    ALLERGY, 2021, 76 : 205 - 205
12345